- Home
- PBYI vs SKBL Comparison
PBYI vs SKBL Comparison
Compare PBYI & SKBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SKBL
- Stock Information
- Founded
- PBYI 2010
- SKBL 2012
- Country
- PBYI United States
- SKBL Hong Kong
- Employees
- PBYI N/A
- SKBL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SKBL
- Sector
- PBYI Health Care
- SKBL
- Exchange
- PBYI Nasdaq
- SKBL NYSE
- Market Cap
- PBYI 138.4M
- SKBL 389.6M
- IPO Year
- PBYI N/A
- SKBL 2025
- Fundamental
- Price
- PBYI $3.07
- SKBL $12.28
- Analyst Decision
- PBYI Strong Buy
- SKBL
- Analyst Count
- PBYI 1
- SKBL 0
- Target Price
- PBYI $7.00
- SKBL N/A
- AVG Volume (30 Days)
- PBYI 275.3K
- SKBL 742.6K
- Earning Date
- PBYI 05-08-2025
- SKBL 01-01-0001
- Dividend Yield
- PBYI N/A
- SKBL N/A
- EPS Growth
- PBYI 37.78
- SKBL N/A
- EPS
- PBYI 0.62
- SKBL 0.03
- Revenue
- PBYI $230,468,000.00
- SKBL $49,638,709.00
- Revenue This Year
- PBYI N/A
- SKBL N/A
- Revenue Next Year
- PBYI N/A
- SKBL N/A
- P/E Ratio
- PBYI $4.92
- SKBL $385.51
- Revenue Growth
- PBYI N/A
- SKBL 9.58
- 52 Week Low
- PBYI $2.23
- SKBL $6.93
- 52 Week High
- PBYI $5.20
- SKBL $13.50
- Technical
- Relative Strength Index (RSI)
- PBYI 51.76
- SKBL N/A
- Support Level
- PBYI $2.88
- SKBL N/A
- Resistance Level
- PBYI $3.14
- SKBL N/A
- Average True Range (ATR)
- PBYI 0.14
- SKBL 0.00
- MACD
- PBYI 0.01
- SKBL 0.00
- Stochastic Oscillator
- PBYI 64.00
- SKBL 0.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SKBL SKYLINE BUILDERS GROUP HOLDING LIMI
Skyline Builders Group Holding Ltd is an holding company operates through its subsidiary. It is a Public Works Contractor company undertaking roads and drainage in Hong Kong. Its construction activities mainly include public civil engineering works, such as road and drainage works, in Hong Kong.